| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/26/2004 | US20040039158 Display long emission wavelengths, long decay times, high quantum yields; covalently linked or associated pairs with long life resonance energy transfer donor, ruthenium-ligand complex, and long wavelength acceptor, Texas Red |
| 02/26/2004 | US20040039116 A solid support comprising a diol group for bonding to oligonucleotides, proteins, cells, and coupling to substrate with a silane compound |
| 02/26/2004 | US20040038997 Method of measuring platelet activation |
| 02/26/2004 | US20040038930 Freeze drying the buffered complex, e.g., ferric hydroxide sucrose, sodium ferric gluconate or ferric saccharate, for subsequent reconstitution for parenteral injection; treating iron deficiency anemia |
| 02/26/2004 | US20040038927 Methods of decreasing or preventing pain using spicamycin derivaties |
| 02/26/2004 | US20040038898 Contacting or admixing with the extracorporeal circulating blood with a Factor IXa compound in an amount effective to inhibit thrombosis |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038875 Alpha 7nicotinic receptor screening assays |
| 02/26/2004 | US20040038862 Assessing ability of compound to act as ligand for short heterodimerizing partner-1 or liver receptor homologue-1, ability of compound to act as ligand for one of these receptors being indicative of modulator of bile acid synthesis |
| 02/26/2004 | US20040038860 Reagents and methods for modulating dkk-mediated interactions |
| 02/26/2004 | US20040038431 Core-shell metal particles coated with dextran or aminodextran carrying sh groups, and use thereof |
| 02/26/2004 | US20040038430 Monoclonal antibodies specific for PHF-TAU, hybridomas secreting them, antigen recognition by these antibodies and their applications |
| 02/26/2004 | US20040038428 For high throughput expression and purification of recombinant proteins; solid phase synthesis; self-assembling |
| 02/26/2004 | US20040038427 Method for detecting and/or quantifying first molecules |
| 02/26/2004 | US20040038426 Measurement of concentrations and binding energetics |
| 02/26/2004 | US20040038424 Formaldehyde-ammonium salt complexes for the stabilization of blood cells |
| 02/26/2004 | US20040038422 For body fluid assays; comprises carousel mounted about a hub, which is disposed in a complementary shaped housing; chromatography |
| 02/26/2004 | US20040038421 Methods for studying ion channels incorporated onto a solid-supported membrane |
| 02/26/2004 | US20040038420 Programmable multiplexed active biologic array |
| 02/26/2004 | US20040038419 Detecting fluorescence by derivatization of cyanide with fluorescing agent (napthalene-2,3-dialdehyde) via spectrometer; nitrilases; high performance liquid chromatography; high throughput assay |
| 02/26/2004 | US20040038418 For proteins/polypeptides within polyacrylamide matrix; mass spectrometry |
| 02/26/2004 | US20040038417 Method for identifying and/or characterizing a (poly)peptide |
| 02/26/2004 | US20040038416 Based on kinetics; quality control kits |
| 02/26/2004 | US20040038414 Method for the pyrolysis of mercuric chloride for the subsquent analysis of the mercury |
| 02/26/2004 | US20040038413 Irradiation of lymphocytes/erythrocytes; comprises photomultiplier tube |
| 02/26/2004 | US20040038412 Measuring expired 13C-labeled carbon dioxide; kits |
| 02/26/2004 | US20040038411 Diagnostic kit with a memory storing test strip calibration codes and related methods |
| 02/26/2004 | US20040038409 Filling rotary chamber made of quartz with hydrogen-argon atmosphere containing silicon fluoride (SiF4) and silane for decomposition/forming pure silicon crystals; for production of solar cells; semiconductors |
| 02/26/2004 | US20040038398 Purification and uses of dendritic cells and monocytes |
| 02/26/2004 | US20040038397 Comprises transfection of neuronal cells with oncogene expression vector; for increased phosphorylation of tau protein |
| 02/26/2004 | US20040038389 Self-contained cholesterol meters; comprises clam-shell case and spring-loaded finger stick |
| 02/26/2004 | US20040038387 Method for producing a 3-D micro flow cell and a 3-d micro flow cell |
| 02/26/2004 | US20040038377 Diagnostic test for Alzheimer's disease |
| 02/26/2004 | US20040038376 Assaying for pepsinogen, gastrin, and Helicobacter pylori concentration; kits |
| 02/26/2004 | US20040038370 Claudin polypeptides |
| 02/26/2004 | US20040038362 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038358 Contains a ubiquitin pathway protein binding moiety which recognizes a ubiquitin pathway protein and a targeting moiety which recognizes a target protein |
| 02/26/2004 | US20040038356 Method and kit for discontinuous density gradient centrifugation to separate a minimum of two substances in a sample; method and kit use is made of colloidal density media and low-density solutions |
| 02/26/2004 | US20040038355 Plate-like magnetic particles |
| 02/26/2004 | US20040038343 Used in the diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections |
| 02/26/2004 | US20040038339 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038329 By using immunoglobulin G2 (IgG2); also by determining the levels of interleukin-4, interferon- gamma and IgG in the subject |
| 02/26/2004 | US20040038328 Assay for melanogenesis |
| 02/26/2004 | US20040038327 Antibodies to polypeptides from coagulase-negative staphylococci |
| 02/26/2004 | US20040038326 Fluorescence-based mucus assay |
| 02/26/2004 | US20040038324 Epothilone resistant cell lines |
| 02/26/2004 | US20040038323 Inhibitors of cell migration and shape changes by inhibiting cortactin and hs-1 medicated actin polymerization |
| 02/26/2004 | US20040038322 Preventing metastasis and tumor expression via gene expression inhibition of kruppel like transcription factor; antisense therapy; antitumor agents; gene silencing agents |
| 02/26/2004 | US20040038321 Immunological test and diagnostic kit for prostate adenocarcinoma |
| 02/26/2004 | US20040038320 Methods of detecting cancer using cellular autofluorescence |
| 02/26/2004 | US20040038319 Labeled diagnostic reagent for use in quanitative proteomics and diagnosing muscular dystrophy |
| 02/26/2004 | US20040038318 Microarray comprised of immobilized monoclonal antibodies for measuring creatine kinase concentration and diagnosing, bone cardiovascular and brain disorders |
| 02/26/2004 | US20040038317 Identifying functional fragment pairs/activation/binding sites in protein for screening and monitoring therapeutic and imaging reagents in vivo; for detection and treatment of cancer, inflammation, atherosclerosis and infection |
| 02/26/2004 | US20040038316 Cell separation device and methods for use |
| 02/26/2004 | US20040038313 Inhibitors of agonist-specific desensitization |
| 02/26/2004 | US20040038311 Antibodies to trisulfated heparin disaccharide in painful sensory axonal neuropathy |
| 02/26/2004 | US20040038310 Inventory control |
| 02/26/2004 | US20040038309 Method and device for nonsynthetic deconvolution |
| 02/26/2004 | US20040038307 Unique recognition sequences and methods of use thereof in protein analysis |
| 02/26/2004 | US20040038306 Compositions and methods for detection and isolation of phosphorylated molecules |
| 02/26/2004 | US20040038305 Using placenta growth factor (PLGF), plasminogen activator inhibitor (PIAs) and/or leptin as screening tools for prediciting toxemia in late pregnancy |
| 02/26/2004 | US20040038301 Method of estimating the properties of a polymer product |
| 02/26/2004 | US20040038300 Method for producing and identifying appropriate effectors of target molecules using substance libraries |
| 02/26/2004 | US20040038299 Composition and method for modulating an inflammatory response |
| 02/26/2004 | US20040038298 Protein fragment complementation assays for the detection of biological or drug interactions |
| 02/26/2004 | US20040038297 Masp-2,a complement-fixing enzyme, and uses for it |
| 02/26/2004 | US20040038296 Multicompartment apparatus associated with solid support and modified analyte-specific binding partner (MASBP) for determining the ratios of biological molecules; determining blood glucose levels of diabetics |
| 02/26/2004 | US20040038295 Assays |
| 02/26/2004 | US20040038294 Hydrophilic chemilumescent acridinium labeling reagents |
| 02/26/2004 | US20040038292 Comprises nucleotide sequences which code wound healing proteins for treatment and prevention of scarring, fibrosis, restenosis post angioplasty, psoriasis, benign prostatic hyperplasia, glaucoma and nervous suystem disorders |
| 02/26/2004 | US20040038291 Comprises immunoglobulin polypeptide library for diagnosis, prevention, suppression and/or treatment of inflammatory, cancer, viral, autoimmune and arthritic diseases |
| 02/26/2004 | US20040038284 Using replication error phenotype (RER) to classify and prognose tumor disorders; immunoassay |
| 02/26/2004 | US20040038281 Isolated ductal fluid sample |
| 02/26/2004 | US20040038279 Comprises ubiquitin conjugating enzyme for diagnosis, prevention and treatment of cell proliferative, immunological, neurological, and reproductive disorders |
| 02/26/2004 | US20040038271 Novel C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 02/26/2004 | US20040038270 Apparatus for identification and visualization of wastewater bacterium |
| 02/26/2004 | US20040038265 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 02/26/2004 | US20040038259 Method of producing a temporally spaced subtracted (TSS) cDNA library and uses thereof |
| 02/26/2004 | US20040038255 Silver-gold shelled composite oligonucleotide conjugate for detecting target nucleic acids, peptides and proteins; colorimetric based DNA detection |
| 02/26/2004 | US20040038251 Illuminating individually-suspended single-wall carbon nanotubes with a radiation, causing the nanotubes to emit near-infrared fluorescence, monitoring fluorescence, exposing nanotube to a chemical species, comparing both fluorescence |
| 02/26/2004 | US20040038244 Comprises expression vector capable of chromosomal insertion and transcription of telomerase for generating transgenic somatic cells and screening and/or identifying antitumor and anticarcinogenic agents |
| 02/26/2004 | US20040038241 Spatially resolved enzyme-linked assay |
| 02/26/2004 | US20040038240 Method and materials for assessing cancer aggressiveness |
| 02/26/2004 | US20040038236 Mutation associated with epilepsy |
| 02/26/2004 | US20040038235 A g-protein coupled receptor |
| 02/26/2004 | US20040038230 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038228 Microphysiometer |
| 02/26/2004 | US20040038227 Using microcalorimetric apparatus to analyze interaction between multiple chemical entities/drugs and trangenic gene product expressed in viable cells |
| 02/26/2004 | US20040038225 Diagnosing, detecting and classifying colon cancer via presence of colon marker polypeptides (COLOUP) |
| 02/26/2004 | US20040038223 Comprise polypeptide for diagnosis, prevention and treatment of cardiomyopathy, atherosclerosis, hypertension, cancer, diabetes and nervous system disorders |
| 02/26/2004 | US20040038220 Methods for categorizing patients |
| 02/26/2004 | US20040038217 Molecular constructs and methods of use for detection of biochemical reactions |
| 02/26/2004 | US20040038214 Using microarray scanner to determine concentration of bound label associated with chemical, biochemical and biomedical analysis |
| 02/26/2004 | US20040038203 Comprises nucleotide sequences coding yaba monkey tumor viral protein for treatment and prevention of autoimmune diseases |
| 02/26/2004 | US20040038200 Using monclonal antibodies to differentiate between pathogenic aggregated protein and nonpathogenic, nonaggregated protein molecules; immunoassay |
| 02/26/2004 | US20040038197 Extraction and concentration method |